Carolin Czauderna

Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation

Massimo Iavarone, Federica Invernizzi, Carolin Czauderna et al. · American Journal of Transplantation · 2019 · 86 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Acquired Resistance to Antiangiogenic Therapies in Hepatocellular Carcinoma Is Mediated by Yes‐Associated Protein 1 Activation and Transient Expansion of Stem‐Like Cancer Cells

Darko Castven, Carolin Czauderna, Diana Becker et al. · Hepatology Communications · 2021 · 49 citations · Full text

Medicine, Oncology, Pharmacology +17

Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers

Fabian Finkelmeier, Carolin Czauderna, Lukas Perkhofer et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 45 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Cabozantinib in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicenter Real-Life Cohort

Fabian Finkelmeier, Bernhard Scheiner, Catherine Leyh et al. · Liver Cancer · 2021 · 40 citations · Full text

Medicine, Oncology, Pharmacology +15

Regorafenib Efficacy After Sorafenib in Patients With Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Retrospective Study

Massimo Iavarone, Federica Invernizzi, Tommy Ivanics et al. · Liver Transplantation · 2021 · 36 citations

Medicine, Oncology, Pharmacotherapy +17